Literature DB >> 3072116

An immunobioluminescence assay for gamma-gamma enolase activity in human serum and cerebrospinal fluid.

R A Wevers1, A W Theunisse, G Rijksen.   

Abstract

A solid phase immunobioluminescence assay for the measurement of gamma-gamma enolase activity in human serum and cerebrospinal fluid is described. The assay combines the specificity of the antiserum with the specificity of measuring enolase activity, thus making the assay highly specific for gamma-gamma enolase. The sensitivity of the method allows determinations in unconcentrated cerebrospinal fluid samples. The new immunobioluminescence assay has been compared with a radioimmunoassay method. The correlation is good both for serum and CSF samples. However, different correlation lines are found for serum and CSF.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3072116     DOI: 10.1016/0009-8981(88)90220-3

Source DB:  PubMed          Journal:  Clin Chim Acta        ISSN: 0009-8981            Impact factor:   3.786


  3 in total

Review 1.  Point-of-Care-Testing in Acute Stroke Management: An Unmet Need Ripe for Technological Harvest.

Authors:  Dorin Harpaz; Evgeni Eltzov; Raymond C S Seet; Robert S Marks; Alfred I Y Tok
Journal:  Biosensors (Basel)       Date:  2017-08-03

2.  Distinction of two different classes of small-cell lung cancer cell lines by enzymatically inactive neuron-specific enolase.

Authors:  T A Splinter; C F Verkoelen; M Vlastuin; T C Kok; G Rijksen; K G Haglid; F Boomsma; A van de Gaast
Journal:  Br J Cancer       Date:  1992-12       Impact factor: 7.640

3.  Use of Tethered Enzymes as a Platform Technology for Rapid Analyte Detection.

Authors:  Roy Cohen; James P Lata; Yurim Lee; Jean C Cruz Hernández; Nozomi Nishimura; Chris B Schaffer; Chinatsu Mukai; Jacquelyn L Nelson; Sharon A Brangman; Yash Agrawal; Alexander J Travis
Journal:  PLoS One       Date:  2015-11-25       Impact factor: 3.240

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.